Clinical trials
Completed Phase 1/2 Osteosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Celgene | 1 |
| Children's Oncology Group | 1 |
| Eisai Limited | 1 |
| Eli Lilly and Company | 1 |
| Grupo Espanol de Investigacion en Sarcomas | 1 |
| Hutchmed | 1 |
| Insmed Incorporated | 1 |
| Institute of Mother and Child, Warsaw, Poland | 1 |
| Isofol Medical AB | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteosarcoma | 16 |
| Rhabdomyosarcoma | 7 |
| Sarcoma | 6 |
| Sarcoma, Ewing | 6 |
| Neuroblastoma | 4 |
| Bone Neoplasms | 3 |
| Chondrosarcoma | 3 |
| Histiocytoma, Malignant Fibrous | 3 |
| Leiomyosarcoma | 3 |
| Sarcoma, Synovial | 3 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.